Stocks and InvestingStocks and Investing
Mon, May 1, 2023
Sun, April 30, 2023
Fri, April 28, 2023

Mohit Bansal Maintained (ABBV) at Buy with Decreased Target to $195 on, Apr 28th, 2023


Published on 2024-10-28 03:09:19 - WOPRAI, Mohit Bansal
  Print publication without navigation


Mohit Bansal of Wells Fargo, Maintained "AbbVie Inc." (ABBV) at Buy with Decreased Target from $200 to $195 on, Apr 28th, 2023.

Mohit has made no other calls on ABBV in the last 4 months.



There are 10 other peers that have a rating on ABBV. Out of the 10 peers that are also analyzing ABBV, 6 agree with Mohit's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Carter Gould of "Barclays" Maintained at Hold with Increased Target to $160 on, Thursday, April 13th, 2023
  • Jasper Hellweg of "Argus Research" Downgraded from Strong Buy to Hold on, Wednesday, April 5th, 2023
  • Tim Anderson of "Wolfe Research" Downgraded from Buy to Hold on, Wednesday, February 22nd, 2023
  • Navin Jacob of "UBS" Maintained at Hold with Increased Target to $152 on, Friday, February 10th, 2023
  • Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $154 on, Friday, February 10th, 2023
  • David Risinger of "SVB Leerink" Upgraded from Sell to Hold and Increased Target to $153 on, Friday, February 10th, 2023


These are the ratings of the 4 analyists that currently disagree with Mohit


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $163 on, Friday, February 10th, 2023
  • Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Buy with Increased Target to $165 on, Thursday, February 9th, 2023
  • Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $180 on, Thursday, February 9th, 2023
  • Gary Nachman of "BMO Capital" Maintained at Buy with Decreased Target to $167 on, Monday, February 6th, 2023